· Discovery
of novel therapeutics for Alzheimer’s disease
· Drug
delivery through the blood-brain barrier (BBB)
· Discovery
of peptide-based checkpoint inhibitors for cancer immunotherapy
· Development
of targeted drug delivery systems for macromolecules
· Discovery
of molecular ligands for imaging, diagnosis, and targeted drug delivery
·
Development of
anti-tumor prodrugs for improving
target-ability and efficiency
· Development
of novel therapeutics for liver diseases